Activities of the pan-Canadian Pharmaceutical Alliance: An Observational Analysis.

CONCLUSION: These findings revealed a strong alignment between HTA recommendations and pCPA negotiations, an implicit prioritization favouring oncology drug negotiations, and an evolving role for health economics in Canada's reimbursement process.
PMID: 30725539 [PubMed - in process]

Source: Journal of Population Therapeutics and Clinical Pharmacology - February 7, 2019 Category: Drugs & Pharmacology Tags: J Popul Ther Clin Pharmacol Source Type: research